))
Is the molnupiravir tablet effective against covid-19?
Manage episode 356896747 series 3382564
Content provided by VOW 88.1. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by VOW 88.1 or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Merck revealed in early October on a promising new pharmacological treatment that might be administered as a tablet in the days following the onset of COVID-19 symptoms to prevent severe disease. This development, which many are applauding as a game-changer, is already changing the debate. The tablet is called molnupiravir and will be given twice a day to vulnerable patients recently diagnosed with the disease.
To further discuss this we are joined by Dr Lize Hellstrom who is one of MERCKs principal investigators in the phase 3 clinical trials.
…
continue reading
To further discuss this we are joined by Dr Lize Hellstrom who is one of MERCKs principal investigators in the phase 3 clinical trials.
150 episodes
Share
